Evaluation of the Bactericidal Activity of Plazomicin and Comparators against Multidrug-Resistant Enterobacteriaceae

Mary Thwaites, Devon Hall, Dean L. Shinabarger, Alisa W. Serio, Kevin M. Krause, Andrea Marra, Chris M. Pillar

Antimicrobial Agents and Chemotherapy · 2018 · 30 citations · 8 references

DOIFull text

Open access

Concepts

Abstract

The next-generation aminoglycoside plazomicin, in development for infections due to multidrug-resistant (MDR) Enterobacteriaceae , was evaluated alongside comparators for bactericidal activity in minimum bactericidal concentration (MBC) and time-kill (TK) assays against MDR Enterobacteriaceae isolates with characterized aminoglycoside and β-lactam resistance mechanisms. Overall, plazomicin and colistin were the most potent, with plazomicin demonstrating an MBC 50/90 of 0.5/4 μg/ml and sustained 3-log 10 kill against MDR Escherichia coli , Klebsiella pneumoniae , and Enterobacter spp.

References

8